Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit.

Tempia Valenta, Silvia et al.·Eating and weight disorders : EWD·2023·

Quick Facts

Study Type

Not classified

Evidence

Not graded

Sample

Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:: Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit.
Published In:: Eating and weight disorders : EWD, 28(1), 99 (2023)
Authors:: Tempia Valenta, Silvia, Stecchi, Michele, Perazza, Federica, Nuccitelli, Chiara, Villanova, Nicola, Pironi, Loris, Atti, Anna Rita, Petroni, Maria Letizia
Database ID:: RPEP-07459

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

What do these levels mean? →

Cite This Study

RPEP-07459·https://rethinkpeptides.com/research/RPEP-07459

APA

Tempia Valenta, Silvia; Stecchi, Michele; Perazza, Federica; Nuccitelli, Chiara; Villanova, Nicola; Pironi, Loris; Atti, Anna Rita; Petroni, Maria Letizia. (2023). Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit.. Eating and weight disorders : EWD, 28(1), 99. https://doi.org/10.1007/s40519-023-01625-5

MLA

Tempia Valenta, Silvia, et al. "Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit.." Eating and weight disorders : EWD, 2023. https://doi.org/10.1007/s40519-023-01625-5

RethinkPeptides

RethinkPeptides Research Database. "Liraglutide 3.0 mg and mental health: can psychiatric sympto..." RPEP-07459. Retrieved from https://rethinkpeptides.com/research/tempia-2023-liraglutide-30-mg-and

Access the Original Study

View on PubMed View via DOI

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database